Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 7771973 Modified nucleotides
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
0
Date Filed
June 1, 2009
0
Date of Patent
August 10, 2010
0
Patent Application Number
12455397
0
Patent Citations Received
US Patent 12121896 Nucleic acid sequencing by synthesis using magnetic sensor arrays
0
US Patent 11773439 Nucleic acid sequencing-by-synthesis (SBS) methods that combine SBS cycle steps
US Patent 11878993 Nucleotide analogues
0
US Patent 11932904 Enhanced optical detection for nucleic acid sequencing using thermally-dependent fluorophore tags
0
US Patent 11940413 Methods and devices for sequencing nucleic acids in smaller batches
0
US Patent 11959137 Synthesis of novel disulfide linker based nucleotides as reversible terminators for DNA sequencing by synthesis
0
US Patent 11958877 Nucleotide analogues
0
US Patent 11970735 Nucleotide cleavable linkers and uses thereof
0
US Patent 11999999 Synthesis of novel disulfide linker based nucleotides as reversible terminators for DNA sequencing by synthesis
0
US Patent 12006540 Synthesis of novel disulfide linker based nucleotides as reversible terminators for DNA sequencing by synthesis
0
•••
Patent Inventor Names
Xiaolin Wu
0
Mark Smith
0
Silke Ruediger
0
Xiaohai Liu
0
Colin Barnes
0
John Milton
0
Joseph Brennan
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
7771973
0
Patent Primary Examiner
Jezia Riley
0
Find more entities like US Patent 7771973 Modified nucleotides
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE